August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Joe Chang: Optimal first-line treatment for EGFR-mutated mNSCLC
Mar 30, 2025, 16:56

Joe Chang: Optimal first-line treatment for EGFR-mutated mNSCLC

Joe Chang, Director of the Stereotactic Ablative Radiotherapy Program at MD Anderson Cancer Center, shared a post on X:

“Optimal first-line treatment for EGFR-mutated mNSCLC?

  1. Tagrisso alone for most patients.
  2. Tagrisso plus chemo for high-risk patients (brain/liver mets or large size)
  3. Amivantamab: Ab EGFR and MET. Lazertinib: EGFR TK

Don’t forget: SABR plus Tagrisso for oligomets or oligoprogression.”

Joe Chang: Optimal first-line treatment for EGFR-mutated mNSCLC

More posts featuring Joe Chang.